Skip to main content
Click Here For COVID-19 Studies
Home
Clinical Trials Office Register as a Researcher Log In
235 Studies Now Enrolling
 Menu
Home How It Works Resources Join RecruitMe

Search

Reset

Status

  • Closed (2)

Medical Condition

  • Show all (89)
  • Autoimmune Disorders (1)
  • Blood Disorders (3)
  • Bone & Muscle (1)
  • Cancer (18)
    • (-) Breast Cancer (1)
    • Gynecologic Cancer (2)
    • Head and Neck Cancer (1)
    • Leukemia (2)
    • Lung Cancer (2)
    • Multiple Myeloma (2)
    • Pancreatic Cancer (1)
    • Solid Tumors (2)
    • Uveal Melanoma (2)
  • COVID-19 (Coronavirus) (4)
  • Diabetes (2)
  • Endocrine & Metabolic Disease (3)
  • Hair and Skin Disorders (1)
  • Healthy Volunteers (12)
  • Heart Disease (17)
  • Kidney Disease (1)
  • Liver Disease (2)
  • Lung Disease (2)
  • Neurological Disorders (3)
    • (-) Alzheimer's Disease (1)
    • Neuropathy (1)
  • Nutrition (2)
  • Obesity (2)
  • Obstetrics & Gynecology (3)
  • Pediatrics (7)
  • Surgery (2)
  • Transplant (3)
Displaying 1 - 2 of 2

TrACER: Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER) for Patients Receiving Chemotherapy

Condition: Cancer / Breast Cancer
Investigator: Dawn Hershman, MD
Status: Closed
This randomized clinical trial studies prophylactic colony stimulating factor management in patients with breast, colorectal or non-small cell lung cancer receiving chemotherapy and with risk of developing febrile neutropenia. Patients receiving chemotherapy may develop febrile neutropenia. Febrile neutropenia is a condition that involves fever and a low…
Read More

A study for patients with Progressive Supranuclear Palsy (PCP) using study drug C2N-8E12

Condition: Neurological Disorders / Alzheimer's Disease
Investigator: Lawrence Honig, MD, PhD
Status: Closed
The purpose of this Phase I study is to see whether a single dose of an experimental drug (meaning a drugthat is not approved by the FDA) called C2N-8E12 given into your vein (called intravenous or IV) is safeand well-tolerated in subjects with Progressive Supranuclear Palsy (PSP). C2N-8E12 is an immunotherapy (antibody) drug designed to bind to and to…
Read More
COMPLIANCE
Compliance Hotline Compliance Program
RESOURCES
Terms of Use Privacy Policy ©2026 Columbia University
SCHOOLS
Vagelos College of Physicians and Surgeons Mailman School of Public Health School of Nursing College of Dental Medicine Graduate School of Arts and Science